Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 1, 2021.
Article Versions
- Latest version (December 15, 2020 - 04:00).
- You are currently viewing a Latest version of this article (May 1, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Elisabeth Mogard,
- Tor Olofsson,
- Stefan Bergman,
- Ann Bremander,
- Lars-Erik Kristensen,
- Jack Kvistgaard Olsen,
- Johan K. Wallman and
- Elisabet Lindqvist
- This work was supported by grants from the Faculty of Medicine at Lund University; Region Skåne; Skåne University Hospital; Spenshult Research and Development Centre; ALF Region Skåne; the Swedish Rheumatism Association; the Anna-Greta Crafoord Foundation; the Kock Foundation; the Österlund Foundation; and the Lundgren Foundation.
E. Mogard, PT, PhD, T. Olofsson, MD, PhD, J.K. Wallman, MD, PhD, E. Lindqvist, MD, PhD, Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology, and Skåne University Hospital, Department of Rheumatology, Lund, Sweden; S. Bergman, MD, PhD, Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology, Lund, Primary Health Care Unit, Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, and Spenshult Research and Development Centre, Halmstad, Sweden; A. Bremander, PT, PhD, Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology, Lund, Spenshult Research and Development Centre, Halmstad, Sweden, Department of Regional Health Research, University of Southern Denmark, Odense, and Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark; L.E. Kristensen, MD, PhD, Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden, and The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Frederiksberg and Bispebjerg, Copenhagen, Denmark; J. Kvistgaard Olsen, BSc, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Frederiksberg and Bispebjerg, Copenhagen, Denmark.
TO has received interview fees from Eli Lilly and provided consultancy for Merck & Co. (unrelated to the present work). LEK has received consultancy and speakers bureau fees from AbbVie, Amgen, Biogen, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Merck & Co., Novartis, Pfizer; Roche, Sanofi, and UCB (unrelated to the present work). JKW has received consultancy fees from AbbVie, Celgene, Eli Lilly, Novartis, and UCB (unrelated to the present work). The remaining authors have no competing interests.
Address correspondence to Dr. E. Mogard, Department of Rheumatology, Skåne University Hospital, Kioskgatan 5, SE-221 85 Lund, Sweden. Email: elisabeth.mogard@med.lu.se.
Accepted for publication December 4, 2020.